Please login to the form below

Not currently logged in
Email:
Password:

RotaTeq

This page shows the latest RotaTeq news and features for those working in and with pharma, biotech and healthcare.

Sanofi unit takes low-cost rotavirus vaccine into phase III

Sanofi unit takes low-cost rotavirus vaccine into phase III

and Merck &Co's RotaTeq which, while effective, are still unaffordable for many countries battling with the infection. ... III trials, promising to make it available at around one-tenth the price of Rotarix and RotaTeq.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics